Murat Koçer - Concepedia

Author

Murat Koçer

Süleyman Demirel University ORCID

Also Known As

E Tiftik, I. Beypinar, M Kocer, M Koçer, M. Kocer, M. Koçer, Murat KOÇER, Murat Kocer, Murat Koçer

Publications

488

Citations

H-Index

Concepts

All Affiliations

Süleyman Demirel University Suleyman Demirel University Akdeniz University Antalya Eğitim ve Araştırma Hastanesi Gazi University

About

Murat Koçer is an author at Süleyman Demirel University specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	195
2	Pathology	4	4	90
3	Health Sciences	1	1	38
4	Cell Biology	1	1	25
5	Epidemiology	1	1	21

Murat Koçer

Publications

351

Citations

H-Index

Page 1

	Year	Citations
Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology Abdurrahman Işıkdoğan, Doğan Koca, Mehmet Küçüköner, Breast Cancer Breast OncologyCapecitabine Combination TherapyMedicineBrain MetastasisClinical Outcomes	2013	38
The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast Nilgün Kapucuoğlu, Kemal Kürşat Bozkurt, Şirin Başpınar, Pathology - Research and Practice Invasive Ductal CarcinomaBreast OncologyMedicinePathologyBreast Cancer	2015	35
Multicenter Epidemiologic Study on Hepatocellular Carcinoma in Turkey Alper Can, Erkan Doğan, İbrahim Vedat Bayoğlu, Asian Pacific Journal of Cancer Prevention	2014	29
Optimal timing of adjuvant treatment in patients with early breast cancer Ayşe Durnalı, Ülkü Yalçıntaş Arslan, Murat Koçer, Medical Oncology Optimal TimingSurgical OncologyBreast OncologyEarly Breast CancerMedicine	2010	26
Survival analysis and factors affecting survival in patients who presented to the medical oncology unit with non-small cell lung cancer Özgür Önal, Murat Koçer, Hande Nur Eroğlu, TURKISH JOURNAL OF MEDICAL SCIENCES	2020	26
Biological Subtypes and Survival Outcomes in Breast Cancer Patients with Brain Metastases (Study of the Anatolian Society of Medical Oncology) Abdurrahman Işıkdoğan, Doğan Koca, Mehmet Küçüköner, Oncology	2012	25
Basic Fibroblast Growth Factor Attenuates Bisphosphonate-Induced Oxidative Injury but Decreases Zinc and Copper Levels in Oral Epithelium of Rat Gülperi Koçer, Mustafa Nazıroğlu, Ömer Çelik, Biological Trace Element Research InflammationMedicineLipid PeroxidationExtracellular MatrixPhysiology	2013	25
Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study. Mehmet Artaç, Nazım Serdar Turhal, Murat Koçer, PubMed	2014	22
A prospectively validated nomogram for predicting the risk of chemotherapy-induced febrile neutropenia: a multicenter study Hakan Bozcuk, Mustafa Yıldız, Mehmet Artaç, Supportive Care in Cancer OncologyPrognosisMetronomic TherapyPathologyValidated Nomogram	2014	21
Do High-risk Features Support the Use of Adjuvant Chemotherapy in Stage II Colon Cancer? A Turkish Oncology Group Study Mehmet Artaç, Nazım Serdar Turhal, Murat Koçer, Tumori Journal	2014	20

Page 1